KeyBanc sees hospitals beating/raising with Q3 earnings
Seeking Alpha News (Fri, 11-Oct 4:49 PM ET)
Buy Rating on Addus Homecare Amid Medicare Expansion and Strategic Growth Opportunities
TipRanks (Fri, 11-Oct 1:35 PM ET)
Addus HomeCare Announces Second Quarter 2024 Financial Results
Business Wire (Mon, 5-Aug 4:05 PM ET)
Addus HomeCare Announces Second Quarter 2024 Earnings Release and Conference Call
Business Wire (Mon, 22-Jul 11:00 AM ET)
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
Addus Homecare trades on the NASDAQ stock market under the symbol ADUS.
As of October 14, 2024, ADUS stock price climbed to $131.81 with 54,062 million shares trading.
ADUS has a beta of 0.71, meaning it tends to be less sensitive to market movements. ADUS has a correlation of 0.12 to the broad based SPY ETF.
ADUS has a market cap of $2.39 billion. This is considered a Mid Cap stock.
Last quarter Addus Homecare reported $287 million in Revenue and $1.35 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.14.
In the last 3 years, ADUS traded as high as $136.12 and as low as $68.57.
The top ETF exchange traded funds that ADUS belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.
ADUS has outperformed the market in the last year with a return of +59.2%, while the SPY ETF gained +35.5%. In the last 3 month period, ADUS beat the market returning +10.0%, while SPY returned +5.3%. However, in the most recent 2 weeks ADUS has underperformed the stock market by returning +0.7%, while SPY returned +2.2%.
ADUS support price is $128.38 and resistance is $132.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADUS shares will trade within this expected range on the day.